营养不良和肌肉减少症在晚期肺癌中的作用。
The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer.
机构信息
Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
出版信息
Curr Oncol Rep. 2020 May 15;22(6):54. doi: 10.1007/s11912-020-00916-9.
Abstract
PURPOSE OF REVIEW
Malnutrition, cancer cachexia, and sarcopenia often co-occur in patients with advanced cancer and are associated with poorer response to chemotherapy and reduced survival. Here, we evaluate the current literature regarding the role of nutrition and these associated conditions in patients with advanced lung cancer.
RECENT FINDINGS
While rates of malnutrition are high, nutritional intervention studies have generally been limited by small sample sizes. Novel strategies such as home-based meal delivery may have promise. While no therapy is approved for cancer cachexia, ghrelin agonists and other targeted therapies have yielded promising data in clinical trials. Recent data also suggest that obesity may improve immunotherapy responsiveness. Malnutrition and associated muscle wasting are clearly negative prognostic markers in advanced lung cancer. Patients with malnutrition should be urgently referred for dietary counseling and guidelines for nutritional support should be followed. Optimal treatment of these syndromes will likely include nutrition and anti-cachexia interventions used in combination.
摘要
目的综述
营养不良、癌性恶病质和肌肉减少症常同时发生于晚期癌症患者，与化疗反应较差和生存时间缩短相关。在此，我们评估了关于晚期肺癌患者营养状况及相关情况的现有文献。
最近的发现
尽管营养不良的发生率很高，但营养干预研究通常受到样本量小的限制。一些新策略，如家庭送餐，可能具有前景。尽管尚无疗法被批准用于癌性恶病质，但胃饥饿素激动剂和其他靶向治疗在临床试验中取得了有希望的数据。最近的数据还表明，肥胖可能改善免疫治疗的反应性。营养不良和相关的肌肉消耗是晚期肺癌明确的预后不良标志物。有营养不良的患者应紧急转介接受饮食咨询，并且应遵循营养支持指南。这些综合征的最佳治疗可能包括联合使用营养和抗恶病质干预。
相似文献
1
The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer.营养不良和肌肉减少症在晚期肺癌中的作用。
Curr Oncol Rep. 2020 May 15;22(6):54. doi: 10.1007/s11912-020-00916-9.
2
Evaluation of Nutrition Status Using the Subjective Global Assessment: Malnutrition, Cachexia, and Sarcopenia.运用主观整体评估法评价营养状况：营养不良、恶病质和肌肉减少症。
Nutr Clin Pract. 2021 Oct;36(5):942-956. doi: 10.1002/ncp.10613. Epub 2020 Dec 29.
3
Dietetic assessment and intervention in lung cancer.肺癌的饮食评估与干预
Curr Opin Support Palliat Care. 2019 Dec;13(4):311-315. doi: 10.1097/SPC.0000000000000453.
4
Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer.妇科癌症中的营养不良、肌肉减少症和癌症恶病质
Gynecol Oncol. 2023 Aug;175:142-155. doi: 10.1016/j.ygyno.2023.06.015. Epub 2023 Jun 27.
5
Impact of musculoskeletal degradation on cancer outcomes and strategies for management in clinical practice.肌肉骨骼退化对癌症结局的影响及临床实践中的管理策略。
Proc Nutr Soc. 2021 Feb;80(1):73-91. doi: 10.1017/S0029665120007855. Epub 2020 Nov 3.
6
An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia.安那莫林作为癌症相关性厌食和恶病质治疗选择的概述。
Expert Opin Pharmacother. 2021 May;22(7):889-895. doi: 10.1080/14656566.2021.1873954. Epub 2021 Jan 25.
7
Feasibility of a multimodal intervention on malnutrition in patients with lung cancer during primary anti-neoplastic treatment.多模式干预在原发性抗肿瘤治疗期间肺癌患者营养不良中的可行性。
Clin Nutr. 2021 Feb;40(2):525-533. doi: 10.1016/j.clnu.2020.05.050. Epub 2020 Jun 9.
8
The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review.根据不同癌症类型和治疗环境，肿瘤患者营养不良/恶病质/肌肉减少症的范围：叙述性综述。
Nutrients. 2021 Jun 9;13(6):1980. doi: 10.3390/nu13061980.
9
[Cachexia and Sarcopenia Associated with Lung Cancer].[与肺癌相关的恶病质和肌肉减少症]
Gan To Kagaku Ryoho. 2020 Nov;47(11):1537-1541.
10
Sarcopenia, Malnutrition, and Cachexia: Adapting Definitions and Terminology of Nutritional Disorders in Older People with Cancer.肌肉减少症、营养不良和恶病质：癌症老年患者营养障碍定义和术语的调整。
Nutrients. 2021 Feb 26;13(3):761. doi: 10.3390/nu13030761.
引用本文的文献
1
Construction of a risk prediction model for falls in elderly lung cancer patients with sarcopenia.老年肺癌合并肌少症患者跌倒风险预测模型的构建
Front Oncol. 2025 Jun 20;15:1533368. doi: 10.3389/fonc.2025.1533368. eCollection 2025.
2
Clinical Significance of Prognostic Nutritional Index in Patients Who Underwent Palliative Surgery for Spine Metastasis.预后营养指数在脊柱转移瘤姑息性手术患者中的临床意义
J Clin Med. 2025 Jun 19;14(12):4372. doi: 10.3390/jcm14124372.
3
Role of diet, physical activity and new drugs in the primary management of cancer cachexia in gastrointestinal tumors - a comprehensive review.饮食、体育活动及新药在胃肠道肿瘤恶病质初级管理中的作用——综述
Front Oncol. 2025 May 30;15:1600425. doi: 10.3389/fonc.2025.1600425. eCollection 2025.
4
Analysis of clinical factors and inflammatory cytokines in patients with lung cancer and sarcopenia: a prospective single-center cohort study.肺癌合并肌少症患者的临床因素及炎性细胞因子分析：一项前瞻性单中心队列研究
Front Oncol. 2025 Apr 8;15:1564399. doi: 10.3389/fonc.2025.1564399. eCollection 2025.
5
Nutritional risk, functional decline, and symptom burden in lung cancer: a study based on PG-SGA scores and biochemical data.肺癌患者的营养风险、功能衰退及症状负担：一项基于患者主观全面评定（PG-SGA）评分和生化数据的研究
Front Nutr. 2025 Apr 3;12:1545177. doi: 10.3389/fnut.2025.1545177. eCollection 2025.
6
The Effect of Nutritional Intervention in Nutritional Risk Screening on Hospitalised Lung Cancer Patients.营养干预对住院肺癌患者营养风险筛查的影响
Nutrients. 2024 Dec 24;17(1):6. doi: 10.3390/nu17010006.
7
Dietary Counseling Outcomes in Patients with Lung Cancer in an Upper-Middle-Income Country: An Open-Label Randomized Controlled Trial.中上收入国家肺癌患者的饮食咨询结果：一项开放标签随机对照试验
J Clin Med. 2024 Sep 4;13(17):5236. doi: 10.3390/jcm13175236.
8
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia.在癌症恶病质中，FcRn 和肿瘤对免疫检查点抑制剂清除率升高的贡献脱钩。
Pharmacol Res. 2024 Jan;199:107048. doi: 10.1016/j.phrs.2023.107048. Epub 2023 Dec 23.
9
Status and influential factors of spiritual well-being in cancer patients with drug clinical trials: a cross-sectional study.癌症患者药物临床试验中精神幸福感的现状及影响因素：一项横断面研究。
Support Care Cancer. 2023 Oct 19;31(12):646. doi: 10.1007/s00520-023-08112-8.
10
The Correlation of Malnutrition with Mortality and Morbidity According to Global Initiative on Malnutrition Criteria in the Palliative Care Unit.根据姑息治疗病房营养不良全球倡议标准，营养不良与死亡率和发病率的相关性
Florence Nightingale J Nurs. 2023 Apr;31(Supp1):S7-S12. doi: 10.5152/FNJN.2023.23062.
本文引用的文献
1
Impact of Baseline Nutrition and Exercise Status on Toxicity and Outcomes in Phase I and II Oncology Clinical Trial Participants.基线营养和运动状态对 I 期和 II 期肿瘤临床试验参与者毒性和结局的影响。
Oncologist. 2020 Feb;25(2):161-169. doi: 10.1634/theoncologist.2019-0289. Epub 2019 Nov 20.
2
Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery.对同源肿瘤模型进行纵向免疫特征分析，以选择用于免疫肿瘤药物发现的模型。
J Immunother Cancer. 2019 Nov 28;7(1):328. doi: 10.1186/s40425-019-0794-7.
3
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?纳武利尤单抗在真实世界非小细胞肺癌患者中是否存在暴露-反应关系？
Cancers (Basel). 2019 Nov 13;11(11):1784. doi: 10.3390/cancers11111784.
4
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients.一项关于转移性非小细胞肺癌、黑色素瘤和肾细胞癌患者纳武利尤单抗药代动力学的前瞻性队列研究。
J Immunother Cancer. 2019 Jul 19;7(1):192. doi: 10.1186/s40425-019-0669-y.
5
Malnutrition in Cancer Care: Time to Address the Elephant in the Room.癌症护理中的营养不良：是时候正视这个显而易见的问题了。
J Oncol Pract. 2019 Jul;15(7):357-359. doi: 10.1200/JOP.19.00165. Epub 2019 Jun 12.
6
Letter to the Editor: Exposure-response or clearance-response relationship in immune checkpoint therapy?-A comment on 'correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer' by Basak et al.致编辑的信：免疫检查点疗法中的暴露-反应或清除-反应关系？——对巴萨克等人《纳武利尤单抗暴露与非小细胞肺癌治疗结果之间的相关性》的评论
Eur J Cancer. 2019 Jun;114:25-26. doi: 10.1016/j.ejca.2019.02.017. Epub 2019 Apr 19.
7
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.帕博利珠单抗对比化疗用于未经治疗、PD-L1 表达、局部晚期或转移性非小细胞肺癌（KEYNOTE-042）：一项随机、开放标签、对照、III 期临床试验。
Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4.
8
The Surprisingly Positive Association Between Obesity and Cancer Immunotherapy Efficacy.肥胖与癌症免疫治疗疗效之间惊人的积极关联。
JAMA. 2019 Apr 2;321(13):1247-1248. doi: 10.1001/jama.2019.0463.
9
Early Intensive Nutrition Intervention with Dietary Counseling and Oral Nutrition Supplement Prevents Weight Loss in Patients with Advanced Lung Cancer Receiving Chemotherapy: A Clinical Prospective Study.早期强化营养干预联合饮食咨询和口服营养补充剂可预防晚期肺癌化疗患者体重减轻：一项临床前瞻性研究。
Yonago Acta Med. 2018 Dec 27;61(4):204-212. doi: 10.33160/yam.2018.12.003. eCollection 2018 Dec.
10
Cancer statistics, 2019.癌症统计数据，2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
Zotero 插件